HK1159113A1 - 作為抗結核病藥的吡啶並嘧啶化合物 - Google Patents
作為抗結核病藥的吡啶並嘧啶化合物Info
- Publication number
- HK1159113A1 HK1159113A1 HK11113868.9A HK11113868A HK1159113A1 HK 1159113 A1 HK1159113 A1 HK 1159113A1 HK 11113868 A HK11113868 A HK 11113868A HK 1159113 A1 HK1159113 A1 HK 1159113A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- tubercular agents
- pyridopyrimidine compounds
- pyridopyrimidine
- compounds
- tubercular
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/18—Testing for antimicrobial activity of a material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/63—Carboxylic acid nitriles containing cyano groups and nitrogen atoms further bound to other hetero atoms, other than oxygen atoms of nitro or nitroso groups, bound to the same carbon skeleton
- C07C255/65—Carboxylic acid nitriles containing cyano groups and nitrogen atoms further bound to other hetero atoms, other than oxygen atoms of nitro or nitroso groups, bound to the same carbon skeleton with the nitrogen atoms further bound to nitrogen atoms
- C07C255/66—Carboxylic acid nitriles containing cyano groups and nitrogen atoms further bound to other hetero atoms, other than oxygen atoms of nitro or nitroso groups, bound to the same carbon skeleton with the nitrogen atoms further bound to nitrogen atoms having cyano groups and nitrogen atoms being part of hydrazine or hydrazone groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/40—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of thiourea or isothiourea groups further bound to other hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
- C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
- C07D223/24—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/40—Nitrogen atoms
- C07D251/48—Two nitrogen atoms
- C07D251/52—Two nitrogen atoms with an oxygen or sulfur atom attached to the third ring carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
- C07D251/40—Nitrogen atoms
- C07D251/54—Three nitrogen atoms
- C07D251/66—Derivatives of melamine in which a hetero atom is directly attached to a nitrogen atom of melamine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
- C07D271/113—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrrole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13228508P | 2008-06-17 | 2008-06-17 | |
PCT/EP2009/004379 WO2010003533A2 (en) | 2008-06-17 | 2009-06-17 | Anti-infective compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1159113A1 true HK1159113A1 (zh) | 2012-07-27 |
Family
ID=41037902
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK11113868.9A HK1159113A1 (zh) | 2008-06-17 | 2011-12-22 | 作為抗結核病藥的吡啶並嘧啶化合物 |
Country Status (10)
Country | Link |
---|---|
US (2) | US8785452B2 (zh) |
EP (2) | EP2730576A3 (zh) |
JP (2) | JP5739329B2 (zh) |
KR (1) | KR101574332B1 (zh) |
CN (2) | CN102105470B (zh) |
AU (1) | AU2009267519B2 (zh) |
BR (1) | BRPI0914254A2 (zh) |
CA (1) | CA2727651C (zh) |
HK (1) | HK1159113A1 (zh) |
WO (1) | WO2010003533A2 (zh) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2011206761A1 (en) * | 2010-01-13 | 2012-07-12 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Anti - infective pyrido (1,2 -a) pyrimidines |
HUP1000034A2 (en) * | 2010-01-21 | 2011-09-28 | Uratim Kft | Pyrido[1,2-a]pyrimidine derivatives and pharmaceutical preparations thereof having anti - mycobacterial activity |
SG10201502109VA (en) | 2010-03-18 | 2015-05-28 | Pasteur Institut Korea | Anti-infective compounds |
ES2539722T3 (es) | 2010-04-28 | 2015-07-03 | Astellas Pharma Inc. | Compuesto de tetrahidrobenzotiofeno |
US9073941B2 (en) | 2010-06-28 | 2015-07-07 | Academia Sinica | Compounds and methods for treating tuberculosis infection |
WO2012057599A1 (en) * | 2010-10-25 | 2012-05-03 | Universiti Sains Malaysia | Anti-mycobacterial agents |
CN103635191A (zh) * | 2011-01-26 | 2014-03-12 | 罗切斯特大学 | 小分子rna酶抑制剂和使用方法 |
US8877940B2 (en) | 2011-02-22 | 2014-11-04 | Institut National De La Recherche Scientifique | Antibiotic tolerance inhibitors |
US20130158112A1 (en) * | 2011-06-20 | 2013-06-20 | Jonathan D. SMITH | Compositions and methods for inhibiting beta amyloid secretion |
CN102871992A (zh) * | 2011-09-30 | 2013-01-16 | 中国医学科学院医药生物技术研究所 | 3,5-二硝基苯甲酰胺在制备抗结核药物中的应用 |
US9453022B2 (en) * | 2012-02-14 | 2016-09-27 | Children's Hospital Medical Center | Use of small molecule inhibitors targeting the interaction between Rac GTPase and p67 (phox) |
KR20130118612A (ko) * | 2012-04-20 | 2013-10-30 | (주)네오믹스 | 신규한 아미노피리딘 유도체 및 이의 용도 |
EP2863910B1 (en) | 2012-06-20 | 2020-03-11 | University Of Virginia Patent Foundation | Compositions and methods for regulating glucose homeostasis and insulin action |
KR102529578B1 (ko) * | 2014-08-29 | 2023-05-09 | (주)아모레퍼시픽 | 신규 아다만탄 유도체 화합물 |
BR112017011335A2 (pt) | 2014-12-02 | 2018-02-20 | Prana Biotechnology Limited | compostos de 4h-pirido[1,2-a]pirimidin-4-ona |
CZ306245B6 (cs) * | 2014-12-11 | 2016-10-26 | Univerzita Karlova v Praze Farmaceutická fakulta v Hradci Králové | Substituovaný fenyltetrazol, jeho použití a farmaceutický přípravek ho obsahující |
CN105712931A (zh) * | 2016-03-16 | 2016-06-29 | 山东师范大学 | 一种7-苯基-5-氧代-4-取代-1,4,5,6,7,8-六氢喹啉-3-羧酸乙酯及其无催化合成方法 |
CA3025768A1 (en) * | 2016-05-27 | 2017-11-30 | Arkansas State University-Jonesboro | Antimicrobial agents and the method of synthesizing the antimicrobial agents |
WO2018183382A1 (en) * | 2017-03-27 | 2018-10-04 | The Regents Of The University Of Colorado, A Body Corporate | Small molecule inhibitors of bacterial efflux pumps and methods of using same |
WO2019040404A1 (en) * | 2017-08-21 | 2019-02-28 | Microbiotix, Inc. | METABOLIC-STABLE METABOLIC-N-ACYLAMINOOXADIAZOLES USEFUL AS ANTIBACTERIAL AGENTS |
US10357485B1 (en) | 2018-09-27 | 2019-07-23 | King Saud University | Anti-cancer compound |
GB2589912A (en) * | 2019-12-12 | 2021-06-16 | Chemestmed Ltd | Method of suppressing cancer by RNA m6A methyltransferase mettl16 inhibitors |
CN112336719A (zh) * | 2020-10-19 | 2021-02-09 | 济南大学 | 一种噻唑衍生物作为α-葡萄糖苷酶抑制剂及其应用 |
CN113214249B (zh) * | 2021-04-23 | 2023-09-19 | 成都大学 | 吡啶并[1,2-a]嘧啶-4-硫酮化合物的合成方法 |
WO2023140709A1 (ko) | 2022-01-21 | 2023-07-27 | 재단법인 한국파스퇴르연구소 | 항박테리아 활성 옥사졸 유도체 화합물 및 이의 의약 용도 |
US20240101510A1 (en) * | 2022-08-31 | 2024-03-28 | Texas Crop Science | Apyrase inhibitors |
EP4345091A1 (en) * | 2022-09-29 | 2024-04-03 | Faculdade de Farmácia da Universidade de Lisboa | Benzoic acid derivatives, methods and uses thereof |
EP4345092A1 (en) * | 2022-09-29 | 2024-04-03 | Faculdade de Farmácia da Universidade de Lisboa | Nitrobenzamide compounds, methods and uses thereof |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU178910B (en) * | 1977-08-19 | 1982-07-28 | Chinoin Gyogyszer Es Vegyeszet | Process for preparing 2,3-disubstituted-4-oxo-4h-pyrido/1,2-a/-pyrimidines |
JPH0655740B2 (ja) * | 1985-09-25 | 1994-07-27 | 塩野義製薬株式会社 | ピリドピリミジン誘導体 |
CA1283411C (en) * | 1985-09-25 | 1991-04-23 | Masami Doteuchi | 9-(substituted thio)-4h-pyrido[1,2-a]-pyrimidin-4-one derivatives |
HU201551B (en) * | 1988-02-03 | 1990-11-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing 4-oxo-4h-pyrido(1,2-a)pyrimidine-3-carboxylic acid amide derivatives and pharmaceutical compositions comprising same |
AU4231293A (en) * | 1992-05-13 | 1993-12-13 | E.I. Du Pont De Nemours And Company | Substituted pyrido(1,2-A)pyrimidinone derivatives as fungicides |
FR2691460B1 (fr) * | 1992-05-21 | 1994-07-22 | Rhone Poulenc Rorer Sa | Nouveaux derives du taxane, leur preparation et les compositions qui les contiennent. |
US7176313B2 (en) * | 2000-02-09 | 2007-02-13 | Daiichi Pharmaceutical Co., Ltd. | Anti acid-fast bacterial agent containing pyridonecarboxylic acids as active ingredient |
US6645505B2 (en) * | 2001-03-27 | 2003-11-11 | Council Of Scientific And Industrial Research | Reporter gene based method for the screening of anti-tuberculosis drugs by using essential and regulatory genes of mycobacteria as drug target |
WO2002087589A1 (fr) * | 2001-04-26 | 2002-11-07 | Daiichi Pharmaceutical Co., Ltd. | Medicament permettant d'inhiber une pompe d'elimination de medicament |
AU2003269346A1 (en) * | 2002-10-16 | 2004-05-04 | Council Of Scientific And Industrial Research | Screening method |
AU2003274652A1 (en) | 2002-10-23 | 2004-05-13 | Obetherapy Biotechnology | Compounds, compositions and methods for modulating fat metabolism |
CN1580276A (zh) * | 2003-07-30 | 2005-02-16 | 中国科学院大连化学物理研究所 | 一种高通量抗结核杆菌药物的筛选方法 |
AU2004276092A1 (en) * | 2003-09-26 | 2005-04-07 | Jubilant Organosys Ltd. | Process for the preparation of risperidone |
WO2005089067A2 (en) * | 2004-03-24 | 2005-09-29 | Rimonyx Pharmaceuticals Ltd. | Screening of anti-viral drugs and pharmaceutical compositions containing thiazolidinone derivatives |
CN101008029A (zh) * | 2006-01-27 | 2007-08-01 | 中国医学科学院医药生物技术研究所 | 以结核杆菌异柠檬酸裂解酶为靶点的抗结核药物筛选模型 |
EP1916249A1 (en) * | 2006-10-10 | 2008-04-30 | LEK Pharmaceuticals D.D. | 3-(benzo[d][1,3]dioxol-5-ylmethyl)-4-(thio)oxo-2-(thio)oxo-azolidin-5-ylidene derivatives as antibacterial agents |
CN1945324A (zh) * | 2006-10-19 | 2007-04-11 | 复旦大学 | 一种筛选结核杆菌耐药蛋白的方法 |
JP2011132142A (ja) * | 2009-12-22 | 2011-07-07 | Kowa Co | エリスロポエチン産生促進作用を有するフェニルオキサジアゾール化合物 |
-
2009
- 2009-06-17 JP JP2011513947A patent/JP5739329B2/ja not_active Expired - Fee Related
- 2009-06-17 EP EP13198407.2A patent/EP2730576A3/en not_active Withdrawn
- 2009-06-17 CA CA2727651A patent/CA2727651C/en not_active Expired - Fee Related
- 2009-06-17 BR BRPI0914254A patent/BRPI0914254A2/pt not_active IP Right Cessation
- 2009-06-17 CN CN200980128440.2A patent/CN102105470B/zh not_active Expired - Fee Related
- 2009-06-17 WO PCT/EP2009/004379 patent/WO2010003533A2/en active Application Filing
- 2009-06-17 KR KR1020117000648A patent/KR101574332B1/ko not_active IP Right Cessation
- 2009-06-17 EP EP09776764.4A patent/EP2310388B1/en not_active Not-in-force
- 2009-06-17 CN CN201410219962.6A patent/CN103983627A/zh active Pending
- 2009-06-17 AU AU2009267519A patent/AU2009267519B2/en not_active Ceased
- 2009-06-17 US US12/999,095 patent/US8785452B2/en not_active Expired - Fee Related
-
2011
- 2011-12-22 HK HK11113868.9A patent/HK1159113A1/zh not_active IP Right Cessation
-
2014
- 2014-04-28 US US14/263,218 patent/US20150018543A1/en not_active Abandoned
-
2015
- 2015-04-23 JP JP2015088505A patent/JP2015187110A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2009267519B2 (en) | 2014-11-27 |
WO2010003533A2 (en) | 2010-01-14 |
BRPI0914254A2 (pt) | 2015-11-03 |
EP2310388A2 (en) | 2011-04-20 |
JP5739329B2 (ja) | 2015-06-24 |
JP2015187110A (ja) | 2015-10-29 |
US8785452B2 (en) | 2014-07-22 |
CN102105470B (zh) | 2014-06-04 |
CN102105470A (zh) | 2011-06-22 |
US20150018543A1 (en) | 2015-01-15 |
CA2727651C (en) | 2016-04-05 |
KR20110029148A (ko) | 2011-03-22 |
WO2010003533A3 (en) | 2010-11-25 |
US20110178077A1 (en) | 2011-07-21 |
JP2011524391A (ja) | 2011-09-01 |
KR101574332B1 (ko) | 2015-12-08 |
CA2727651A1 (en) | 2010-01-14 |
AU2009267519A1 (en) | 2010-01-14 |
CN103983627A (zh) | 2014-08-13 |
EP2730576A3 (en) | 2014-09-03 |
EP2310388B1 (en) | 2015-08-05 |
EP2730576A2 (en) | 2014-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1159113A1 (zh) | 作為抗結核病藥的吡啶並嘧啶化合物 | |
GB0810902D0 (en) | New compounds | |
GB0807862D0 (en) | Compounds | |
GB0800035D0 (en) | Compounds | |
IL210935A0 (en) | Anti-malarial compounds | |
GB0809776D0 (en) | Compounds | |
IL210344A0 (en) | New compounds | |
GB0807103D0 (en) | Compounds | |
GB0800367D0 (en) | Compounds | |
HU0800478D0 (en) | New compounds | |
GB0807910D0 (en) | Compounds | |
GB0801220D0 (en) | Compounds | |
GB0801265D0 (en) | Compounds | |
GB0810792D0 (en) | New compounds | |
GB0810619D0 (en) | Compounds | |
GB0808123D0 (en) | Compounds | |
GB0800841D0 (en) | Compounds | |
GB0801596D0 (en) | Compounds | |
GB0802191D0 (en) | Compounds | |
GB0802192D0 (en) | Compounds | |
GB0802231D0 (en) | Compounds | |
GB0802587D0 (en) | Compounds | |
GB0803495D0 (en) | Compounds | |
GB0800455D0 (en) | Compounds | |
GB0803496D0 (en) | Compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20180617 |